Clinical Scorecard: Differentiating Between Benign and Malignant Thyroid Nodules Through Virtual Biopsy: An Investigation Utilizing Quantitative Metrics and Traditional Radiomic Features from Dual-Energy CT Imaging

At a Glance

Key Highlights

• Thyroid nodules are prevalent (~67%) with a malignancy rate of 10-15%, necessitating accurate differentiation to guide treatment.
• Dual-energy CT (DECT) provides advanced imaging with quantitative iodine concentration and effective atomic number (Zeff) parameters aiding in lesion characterization.
• Radiomics analysis of DECT images enhances tumor heterogeneity assessment, improving differentiation between benign and malignant nodules beyond conventional imaging.

Guideline-Based Recommendations

Diagnosis

• Use ultrasound as first-line imaging for thyroid nodule detection per American Thyroid Association guidelines.
• Supplement ultrasound with DECT imaging to obtain quantitative iodine parameters and three-dimensional anatomical information.
• Apply radiomics analysis on DECT images to improve diagnostic accuracy in differentiating benign from malignant nodules.

Management

• Monitor benign thyroid nodules or treat with less invasive methods.
• Manage malignant nodules with more intensive interventions including surgery and radioactive iodine therapy.

Monitoring & Follow-up

• Use DECT quantitative parameters and radiomics features for preoperative evaluation and treatment response assessment.
• Exclude cystic areas, calcifications, and necrosis in quantitative measurements to ensure accuracy.

Risks

• Ultrasound diagnostic accuracy depends on operator expertise and has limitations in feature overlap.
• MRI is limited by contraindications and sensitivity to calcifications.
• Conventional CT lacks the advanced tissue characterization capabilities of DECT.

Patient & Prescribing Data

215 patients undergoing preoperative DECT thyroid enhancement with confirmed pathology

DECT combined with radiomics provides higher accuracy in differentiating benign and malignant nodules, potentially reducing unnecessary invasive procedures and optimizing treatment planning.

Clinical Best Practices

• Perform DECT imaging with iodine-based contrast and reconstruct virtual monoenergetic and material decomposition images.
• Measure iodine concentration and effective atomic number on arterial and venous phase images excluding non-solid components.
• Incorporate radiomics feature extraction from DECT images to assess tumor heterogeneity and malignancy risk.
• Randomly divide patient data into training and test cohorts to validate diagnostic models.
• Use standardized imaging protocols including contrast administration and reconstruction parameters to ensure reproducibility.

References

• American Thyroid Association Guidelines
• Liu et al. on DECT quantitative assessment
• Zhou et al. on radiomics predicting lymph node metastasis